Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial
Pollard, Richard B, MD, Rockstroh, Jürgen K, MD, Pantaleo, Giuseppe, MD, Asmuth, David M, MD, Peters, Barry, MD, Lazzarin, Adriano, Prof, Garcia, Felipe, MD, Ellefsen, Kim, MSc, Podzamczer, Daniel, MD, van Lunzen, Jan, MD, Arastéh, Keikawus, MD, Schürmann, Dirk, MD, Clotet, Bonaventura, MD, Hardy, W David, MD, Mitsuyasu, Ronald, MD, Moyle, Graeme, MD, Plettenberg, Andreas, MD, Fisher, Martin, MD, Fätkenheuer, Gerd, MD, Fischl, Margaret, MD, Taiwo, Babafemi, MD, Baksaas, Ingebjørg, PhD, Jolliffe, Darren, MSc, Persson, Stefan, PhD, Jelmert, Øyvind, MSc, Hovden, Arnt-Ove, PhD, Sommerfelt, Maja A, PhD, Wendel-Hansen, Vidar, Dr, Sørensen, Birger, MSc
Published in The Lancet infectious diseases (01.04.2014)
Published in The Lancet infectious diseases (01.04.2014)
Get full text
Journal Article